Hoyland
Bit confused there. Benitec paid Tacere in shares for there programs yeah..
Benitec Biopharma will acquire Tacere's extensive HCV program data and materials, as well as
an advanced preclinical program for the eye disease macular degeneration, which also utilises
the Company’s ddRNAi technology.
Then this.
Sydney, Australia and San Jose, California 11th October 2012: Benitec Biopharma (ASX: BLT)
today announced the execution of an agreement to acquire the US.based RNA interference
(RNAi) therapeutics company Tacere Therapeutics, Inc.
http://www.benitec.com/documents/12%2010%2011%20BLT%20Tacere%20Program%20Acquisition.pdf
Bit confusing. says two different things. Though they paid for it in shares so they cant just pay themselves?
------------------
Maxineamillion, i cant believe it either about BLTOB. $500 worth why would you bother. Maybe its the guys waiting at .001 trying to hoax out more. Management have not helped there own cause. With that many share at .002 traders could hold it there forever.
- Forums
- ASX - By Stock
- bltob
HoylandBit confused there. Benitec paid Tacere in shares for...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some